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Two /?-a&r mutants, one with proline 38 replaced with alanine (P38A) and the other with cysteine-374 replaced with serine (C374S), as well as 
the wild-type/I-actin, were expressed in the yeast, S. cerevisiae, purified to homogeneity, and analyzed in vitro for polymerizability and interaction 
with DNase I, myosin, and profllin. Both mutations interfered with the polymerization of the actin, and with its interaction with myosin. The C374S 
mutation had the most pronounced effect; it reduced the polymerizability of the actin, abolished its binding to prohlin, and filaments containing 
this mutation moved at reduced rates in the in vitro ‘motility assay’. The ATPase activity measured in solutions containing myosin subfragment 
1 was similar for both the mutant and wild-type actins. 
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1. INTRODUCTION 
The relationship between the crystal structure of actin 
[l] and its functions in various contexts is currently 
subject to intensive investigation (for reviews see [2-61). 
Site-specific mutagenesis, coupled with analysis of the 
properties of the mutagenized actin alone, together with 
myosin, and together with other actin-binding proteins, 
is used in searching for amino acid residues or structural 
domains in actin that are crucial to the transduction of 
energy by the system [7-131. Such in vitro studies are 
complemented by studies of the effect of the specific 
mutagenesis in vivo using different model systems [14- 
181. 
Saccharomyces cerevisiae containing actin mutated at 
position 32 has a temperature-sensitive phenotype and 
an aberrant actin organization [193, and limited proteol- 
ysis of actin in this region interferes with the transloca- 
tion of actin filaments in the in vitro ‘motility assay’ 
[20]. This position is close to residues 3946, which have 
been suggested to form a major interaction surface for 
the binding of DNase I [2], and to participate in mono- 
mer:monomer associations in the actin filament [21]. 
This DNase I binding loop is located in subdomain II 
of actin, while Cys-374 is found in the opposite end of 
the monomer where it constitutes part of the profilin 
binding site [22,23]. The adjacent C-terminal residue, 
Phe-375, has been suggested to participate in monomer 
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interactions in the actin filament [21]. In addition, a 
mutation at position 372 in the actin of the indirect 
flight muscle of Drosophila impairs its flight capacity 
[14], and there is evidence that residues adjacent o C374 
somehow participate in the association with myosin 
[24-261. Therefore it is of interest to mutagenize these 
regions of the actin to locate the sites involved in the 
actin-actin interaction and in actomyosin-based energy 
transduction. 
We have described the expression and isolation of 
mutant/%actins from the yeast S. cerevisiae [9-l 11. Here 
two such mutations, one with proline at position 38 
replaced by alanine (P38A), and a second replacing cys- 
teine at position 374 with a serine residue (C374S), were 
studied using an arsenal of assays probing for the 
actin:actin interaction, actomyosin complex formation 
and force generation. In addition, the binding of the 
mutant actins to DNase I, and profilin were investi- 
gated. 
2. MATERIALS AND METHODS 
2.1. Chemicals and the DNase I affinity column 
Adenosine triphosphate (ATP), dithiothreitol (D’IT) and bovine 
pancreatic deoxyribonuclease I (DNase I; EC 3.1.21.1) were from 
Boehringer, Mannheim. Hydroxyapatite (Hypatite C, lot No. 6654) 
was from Clarkson Chemical Co., Williamsport, PA, USA. Cyanogen 
bromide-activated Sepharose 4B (Pharmacia-LKB, Sweden) was cou- 
pled with 500 mg DNase I according to the instructions provided by 
the manufacturer but excluding the recommended washing of the resin 
at low pH. The volume of the column was 80 ml. 
2.2. Production of recombinant actin 
Manipulations of DNA followed standard protocols [271 and the 
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amino acid replacements were introduced by oligodeoxynucleotide- 
directed mutagenesis. The expression and preparation of the wild-type 
and mutant B-actins were performed using the S. cerevisiue strain, 
K923 (HMLa, mat::LELr2+, hmr::TRPI+, ura3, ad&, sirjts, MATa 
at 23”C, MATcl at 34°C) as previously reported [9-l 1,281. 
2.3. Protein preparattons 
Myosin subfragment-l (Sl) was prepared by cbymotryptic leavage 
of rabbit skeletal muscle myosin 1291 and stored at -20°C in 5 mM 
imidazole, pH 7.0, 15 mM NaCl, 0.1 mM pbenylmethylsulfon- 
ylfluoride and 50% glycerol. 
Human profilin was expressed in S cerevisfae and isolated as de- 
scribed in [30] except that a 100-360 mM KC1 gradient was used to 
elute the material from the phosphocellulose Pl 1 column. This led to 
the separation of two species of the recombinant profilin; one with a 
blocked and one with an unblocked N-terminus [31]. In the interaction 
studies with actin presented here, only N-terminally blocked profilin 
was used. 
Protein concentrations were determined by the method of Bradford 
[32] or spectrophotometrically at 290 nm for actin using an extinction 
coefficient of 0.63, and at 280 nm for Sl and profilin using extinction 
coefficients of 0.75, and 1.1, respectively. 
2.4. ~iectrop~ores~ 
This was carried out in SDS~ntaining 15% ~lya~l~ide gels 
(SDS-PAGE) according to Matsudaira and Burgess f333; isoelectric 
focusing was done in flat-bed gels with a pH range of 5.0-7.0 as 
described previously [IO]. 
2.5. Assays 
The DNase I inhibition was assayed according to Blikstad et al. [34] 
using a Shimadzu UV-ZIOIPC. 
For determination of A, (the critical concentration of actin), actin 
samples (0.3 mg/ml in 300~1 G-buffer) were incubated with salt (2 mM 
MgCl, or 100 mM KCI) for 2 h at 25°C after which the DNase I 
inhibition assay was used to determine the concentration of the un- 
polymerized actin (A,), as described before [9]. 
The viscosity analysis was performed at 25°C using Cannon-Man- 
ning viscometers and 0.7 ml samples containing 0.5 m&ml of actin. 
The actin-activate Sl ATPase activity was determined at 25°C in 
G-buffer containing 2 mM MgCl,, 25 .@rnl Sl , and varying concen- 
trations of filamentous actin in a total vohmre of 0.5 ml to which 1 &i 
of [j2P]ATP was added. Aliquots of 100 ,ul were withdrawn at 3 min 
intervals and inorganic phosphate was determined by the method of 
Seals et al. [35]. The data obtained were aligned to Michaelis-Menten 
kinetics using non-linear regression analysis (Enzhtter, Biosoft). 
The motility assay was performed as described by Kron and Spu- 
dich [37]. Rabbit skeletal muscle myosin (100-300 &ml) in 25 mM 
imidazole, pH 7.0, 25 mM KCI, 5 mM MgCl,, 100 mM DTT (assay 
buffer) was coated on a glass coverslip, and subsequently exposed to 
wild-type and mutant actin filaments labeled with rhodamine phal- 
loidin (Molecular Probes, OR, USA). After addition of assay buffer 
containing 1 mM ATP, filament movement was followed using a Zeiss 
photomicro~pe III equipped for epifluorescence. Video recordings 
were made with a CCD camera ~C2~), an image intensifier and a 
processor (Argus-IO) from Hamamatsu Photonics, and a super-VHS 
videorecorder from Panasonic. For determination of the velocities of 
the moving filaments, the video signal was time-base corrected with 
a 780 Synchronizer-TBC (BLT). The velocity of an individual filament 
was determined from the video recordings by a minimum of 5 meas- 
urements of the distance translocated per unit time. To avoid the 
influence of ‘staling’ during the translocation, video sequences (re- 
corded at 30 frames/s) were selected after ‘frame-by-frame’ analysis, 
and, although the velocity determinations were made over relatively 
short periods of time (usually 2-8 s), only those filaments that per- 
formed a longer continuous movement were chosen for this purpose. 
All three actins were analyzed with the same myosin preparation and 
during the same experimental session to avoid changes in velocity due 
to alterations in the quality of the myosin or to changes in the condi- 
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tions. The velocity of wild-type actin from time to time was highly 
reproducible; e.g. 2.7 pus (2.703) S.D. = 0.55, n = 11 obtained in the 
current study is to be compared with 2.7,uuls (2.724) S.D. = 0.47, n = 34 
obtained 12 months earlier (the P value is 0.91). 
2.6. Binding studies 
The profilin:actin interaction was studied by adding yeast-expressed 
human profilin (see above) in increasing amounts to samples of G- 
actin in G-buffer. Polymerization was then initiated by the addition 
of MgCl, to 2 mM. After incubation for 2 h at room temperature the 
extent of pol~e~tion was determined by DNase I inhibition meas- 
memen~ directly on the samples as well as on su~rna~nts obtained 
by centr~u~tion at room temperature in a Beckman airfuge for 20 
min at 30 psi. The Kd,% values were estimated as described in [30,38]. 
3. RESULTS 
3.1. DNa.se I inhibition and polymerizing activity 
The two actin mutants, P38A and C3’74S, were iso- 
lated from yeast homogenates by affinity chromatogra- 
phy on DNase I-Sepharose. This, and the observed 
specific DNase I inhibiting activities of the mutants 
(Table I), shows that the ability of the mutant actins to 
bind DNase I had not changed si~ifi~ntly compared 
to wild-type actin. The mutations also did not change 
the electrophoretic mobility of the actin in poly- 
acrylamide gels, or change its behaviour during isoelec- 
trofocusing (Fig. 1). 
However, both the P38A and the C374S mutations 
interfered with the polymerization of the actin, and the 
two actins differed in their response to MgClz and KC1 
as shown in Table I and Fig. 2. The critical concentra- 
tion for polymerization in the presence of 2 mM MgCl, 
(A,,,& as measured with the DNase I inhibition assay, 
was 0.03 mg/ml for wild-type actin, 0.04 mg/ml for 
P38A, and 0.16 mg/ml for C374S actin. The correspond- 
ing values measured under KC1 conditions were 0.16, 
0.25, and 0.26 mg/ml, respectively. Thus, whereas the 
A+,g for P38A actin remained close to that of wild-type 
actin, the Acc,Mg for C374S was increased more than 5 
times. This demonstrates that the C-terminus of actin 
Table I 
Critical concentration of polymerization (&) for wild-type and mu- 
tant actins as determined with the DNase I inhibition assay 
Actin %, Specific activity 
Mg2 Mg*++E” K’ K’+E* U/mgb 
(mg/ml) 
Wild-type 0.029 0.025 0.159 0.062 41,749 
(S.D./n) 0.006/6 0.005/7 0.01017 0.005/6 2,058/5 
P38A 0.037 0.039 0.245 0.080 39,128 
(S.D.ln)c 0.012/13 0.010/13 0.016/11 0.0197/8 2,345/8 
c374s 0.159 0.157 0.263 0.197 38,803 
(S.D./n) 0.008/9 0.01219 0.01717 0.033/10 5,350/8 
a [Ethylenebis(oxonitrilo)]te~~tic acid (BGTA). 
b DNase I inhibition units Per mg of actin as defined in f34]. 
‘SD. = standard deviation. n = number of observations. 
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Fig. 1. The homogeneity of the yeast-expressed /3-actins as seen by 
polyacrylamide gel-electrophoresis (a), and isoelectrofocusing (b). 
Lanes displaying wild-type actin are denoted WT, and those with 
mutant actins, P38A and C374S. 
plays an important role in the polymerization process. 
The increased A, values observed for the mutant actins 
in KC1 conditions implies that both subdomains I and 
II of actin [l] participate in monomer:monomer interac- 
tions in the actin filament. 
Fig. 2 shows the results of the viscosity analysis of the 
polymerization of the two mutant actins as compared 
to wild-type actin. In MgCl, all three actins reached half 
maximal viscosity 2-4 min after the initiation of the 
reaction. The only significant difference between the 
three actins was that the C374S actin reached a lower 
steady-state level of viscosity. These assays were per- 
formed with samples containing 0.5 mg/ml actin. Since 
the Acc,Mg value for the wild-type actin obtained with the 
DNase I inhibition assay was 0.03 mg/ml, the relative 
viscosity at steady state, 1.24, corresponds to a polymer- 
ization of 94% of the actin. Assuming a linear relation- 
ship between the concentration of filamentous actin and 
the relative viscosity, and that the overall hydrodynamic 
properties of the wild-type and mutant filaments are 
similar, the A,,‘s can be calculated. The observed rela- 
tive viscosities at steady state for the P38A and C374S 
mutant actins (1.26 and 1.20, respectively) give &,Mg 
values (0.02 mg/ml and 0.13 mg/ml) which are in reason- 
able agreement with those obtained by the DNase I 
inhibition assay (0.04 and 0.16 mg/ml, respectively), 
suggesting that P38A actin polymerized like wild-type 
actin whereas the polymerization of C374S actin was 
reduced by 25-30%. However, ultracentrifugation of 
the samples before determination of DNase I inhibition 
(see profilin interaction studies below) suggested that 
the DNase I inhibition activity determined for C374S 
actin, to a large extent (approximately 70%), was caused 
by actin in a pelletable form. The reason for this dis- 
crepancy is unclear. It is possible that it is due to rapid 
depolymerization of a fraction of the actin during the 
DNase I inhibition assay itself. Another possibility is 
that the mutant actin filaments themselves bind DNase 
I. 
The filament formation is less efficient when induced 
by K’ ions [9,10,38], therefore, these conditions probe 
more subtle influences by the mutations on the polymer- 
ization process than those which include M$‘. Under 
KC1 conditions the kinetics of filament formation with 
both mutant actins differed from that of wild-type actin. 
The P38A actin reached half maximal viscosity only 
after 47 min as compared to 25 min for wild-type actin. 
At the protein concentration used the C374S actin did 
not lead to any detectable filament formation. However, 
the rapid increase in viscosity seen on addition of MgCl, 
demonstrated that the C374S actin was still capable of 
forming filaments (Fig. 2). Thus, qualitatively the vis- 
cosity analysis was in agreement with the results ob- 
tained with the DNase I inhibition assay. With the wild- 
type actin also, the apparent extent of polymerization 
was the same when either the DNase I inhibition assay 
or viscosity analysis was used (compare &,k = 0.16 
mg!ml with rre, = 1.18 *A, = 0.17 mg/ml), but with 
the mutant actins this was not the case. With P38A actin 
i 
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Fig. 2. The polymerizability of the wild-type and mutant actins ana- 
lyzed by viscosity measurements. The relative viscosity (7) of samples 
containing the different actins (labeled as in Fig. 1) was determined 
as a function of time after addition of salt. (0) 100 mM KCI; (0) 2 mM 
MgCI,; (A) 100 mM KC1 + 0.3 mM EGTA. The arrow in the C374S 
actin (bottom) panel indicates addition of MgCl, to 2 mM to the 
KC1 sample. 
165 
Volume 329, number I,2 FEBSLE~ERS August 1993 
I I I 
I I I 
C3745 (% of total) 
Fig. 3. Co-polymerization of wild-type and C374S mutant actin. 
The ADc,ng was determined by the DNase 1 inhibition assay for the 
different combinations of the two actins. The concentration of actin 
was 0.3 mglml. Error bars indicate the variation in two or three 
determinations. 
the viscosity analysis suggested a more efficient polym- 
erization than was indicated by the DNase I inhibition 
assay, qre, = 1.21 instead of 1.14 as derived from the 
A value. This suggests that the P38A mutation 
ch?&ed the DNase I binding characteristics of the 
actin, possibly by also making the DNase I binding site 
on actin available in the filament. With C374S actin, on 
the other hand, no polymerization was observed with 
the viscosity assay, indicating that stable filaments were 
not formed in KC1 conditions. Hence, either these fila- 
ments were extremely fragile, or of oligomer length 
only. 
The effect of the C374S mutation on actin polym- 
erization was studied further by measuring the AccqMg in 
mixtures of mutant and wild-type actin. As shown in 
Fig. 3 the &,Mg was nearly doubled when the mutant 
protein amounted to 25% of the total actin. When the 
mutant and wild-type actins were present in equimolar 
amounts, the Acc,Mg value was already 5-times that ob- 
tained with wild-type actin alone, or equal to the Acc,Mg 
of isolated C374S actin. This shows that the two actin 
species formed co-polymers, and that monomer interac- 
tions other than those involving residue 374 can not 
balance the deleterious effect of the C374S mutation. 
Thus, the C-terminus of actin plays a central role in 
filament formation. 
As observed previously, EGTA influences KCl-in- 
duced polymerization such that it becomes similar to 
that seen with MgCl,. This is particularly prominent 
with non-muscle actins, and in the case of &actin it has 
been suggested that an additional Ca**-binding site is 
presence on the molecule [10,36]. Therefore the polym- 
erization behaviour of the r~ombinant actins was also 
analyzed in conditions where EGTA had been added to 
a concentration of 0.3 mM. This results in a free [Ca*‘] 
of lo-’ M, which is about two orders of magnitude 
above the I(diss for the high-affinity Ca2+ binding site on 
actin. Previously, we have reported that this treatment 
has no influence on Mg*+-induced polymerization, 
while it enhances the polymerizability in KC1 conditions 
[9,10]. This was also the case in the current study. With 
both wild-type and mutant actins, EGTA reduced the 
A values towards those obtained in the presence of 
MF ions (Table I). The C374S mutant actin did not 
respond to the removal of Ca” to the same extent as the 
P38A and wild-type actin. with the C374S actin the 
reduction in &,k was 29% as compared to 62 and 68% 
for wild-type and P38A actin, respectively. The reason 
for this is unclear but is consonant with the more 
Fig. 4. Decoration of wild-type and mutant actin tihunents with myosin subfra~ent 1. (a and b) Wild-type actin; (c and d) P38A actin; and 
(e and f) C374S actin. The specimens were stained with 0.25% uranyl acetate. Bar = 50 nm. 
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Fig. 5. ActoSl-ATPase activities with the wild-type and mutant actins. 
The solid line (0) indicates the result with wild-type actin, and that of 
P38A and C374S actin is shown by a dotted (A) and a dashed line (o), 
respectively. The concentration of filamentous actin was calculated on 
the basis of the A_ for the different actins, and the plot was obtained 
by a best-fit alignment o Michaelis-Menten kinetics using the Biosoft 
Enztitter program. 
strongly disturbed polymerization behaviour for the 
C374S mutant actin. 
3.2. Myosin interaction 
Decoration of P38A and C374S mutant actin fila- 
ments with myosin subfragment 1 (Sl) resulted in the 
typical acto-Sl arrowhead pattern (Fig. 4). Thus, nei- 
ther mutation seemed to influence the formation of 
rigor links with myosin. As shown in Fig. 5, the ATPase 
activity obtained with Sl and the mutant actin filaments 
in solution were close to that obtained with wild-type 
actin. This suggests that residues P38 and C374 are of 
minor importance to the step in the actomyosin interac- 
tion that results in product release from the myosin. 
However, when probing for the ability of the actin 
filaments to translocate on immobilized myosin in the 
in vitro motility assay, both the P38A and C374S muta- 
tions showed a decreased activity. The P38A actin fila- 
ments moved with a mean velocity of 2.2 pm/s 
(S.D. = 0.5; n = 22), and with C374S mutant actin the 
corresponding value was 1.8 pm/s (S.D. = 0.4; n = 19). 
This is compared to 2.7 pm/s (S.D. = 0.6; n = 11) for 
wild-type actin. The 33% reduction in the rate of 
translocation of the C374S mutant actin is highly signif- 
icant with P = 0.0002 in a two sample t-test, while the 
effect of the P38A mutation was less dramatic (18% 
reduced velocity; P = 0.03). Thus, the two mutations 
appear to discriminate between two steps in the acto- 
myosin interaction; one expressed as binding of myosin 
subfragment Sl and ATPase activity in solution, and 
the other observed as translocations of the filaments in 
the in vitro motility assay. 
3.3. Projilin interaction 
Profilin inhibits the polymerization of wild-type /I- 
actin in the presence of 2 mM MgCl,, as shown in Fig. 
6. The inhibitory effect is seen already at a prolilin:actin 
molar ratio of 0.2. At a molar ratio of 1, there was a 
6-fold increase in the concentration of unpolymerized 
actin in steady state with filamentous actin (from 0.03 
mg/ml to 0.18 mg/ml). The P38A actin behaved simi- 
larly, reaching plateau values of unpolymerized actin at 
molar ratios of profilin:actin of about 1.5:1. 
Supernatants, obtained by high-speed centrifugation 
of samples containing actin polymerized in the presence 
of increasing amounts of prohlin, were also analysed 
using the DNase I inhibition assay as shown in Fig. 6b. 
This procedure which avoids an over-estimation of un- 
polymerized actin because of filament ends interacting 
with DNase I, had a prominent effect on the DNase I 
inhibition activity determined for the C374S actin. As 
already mentioned, results obtained after ultracentrifu- 
gation suggested a lower A, value for this mutant actin 
(0.039 mg/ml), while this procedure only marginally in- 
fluenced the A, values determined for the wild-type and 
P38A actins (A, = 0.017 mg/ml in both cases). In the 
presence of profilin, however, also the wild-type and 
P38A actins showed a reduced DNase I inhibition activ- 
ity after centrifugation, suggesting the presence of pelle- 
table and DNase I-interacting complexes of actin under 
these conditions. From the data in Fig. 6b, the dissoci- 
ation coefficient (&J for the profilin:actin interaction 
was determined at 0.3 ,uM (S.D. = 0.2) and 0.9 PM 
(S.D. = 0.9) for the profilin:P38A actin and 
profilin:wild-type actin, respectively (P = 0.0086). The 
somewhat tighter interaction of profilin with P38A 
actin, as compared to that with wild-type actin, thus 
seems to indicate that changes in subdomain II may 
influence the profilin:actin interaction, although the 
I I I 
a b 
Profilin : Actin (molar ratio) 
Fig. 6. Formation of profilin:actin complexes in the presence of 2 mM 
MgCl*. The samples containing profilin and actin (0.3 mg/ml) in the 
molar ratios indicated on the abscissa were analyzed for the presence 
of unpolymerized actin by the DNase I inhibition assay before (a) and 
after (b) ultracentrifugation. Mean values of 2-4 determinations ob- 
tained with wild-type actin (circles), and with P38A and C374S actin 
(triangles and squares, respectively). 
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major pro&n binding site on actin is located in subdo- 
mains I and III (C.E. Schutt et al., submitted). 
When profilin was added to C374S mutant actin, on 
the other hand, there was no inhibition of the polymer- 
ization of the actin. The level of polymerization was in 
agreement with the A, value determined for this actin, 
and it remained constant regardless of the presence of 
increasing concentrations of profilin (Fig. 6). This result 
therefore confirms earlier observations that manipula- 
tions with the C-terminus of actin interfere with the 
prof%n:actin interaction, and it emphasizes the central 
role of residue C374 in forming the pro~in-bin~ng site 
on actin. The same result was obtained when analyzing 
the high-speed supernatants (Fig. 6b) except for the 
observation that a major part of the DNase I inhibiting 
activity was pelletable as described above. 
4. DISCUSSION 
The P38A mutation introduced intop-actin is located 
close to the surface loop contributing to the major 
DNase I binding site (residues 38-45) on subdomain II 
[2]. However, as shown here, the P38A mutation did not 
seriously influence the ability of the actin to bind to 
DNase I. This is ~derstandable since this amino acid 
replacement should merely increase the flexibility of the 
polypeptide chain in the neighbourhood of P38. Also, 
the additional DNase I-binding sites present on subdo- 
mains II and IV of actin [2] might guide DNase I into 
an interaction of similar tightness as that seen with wild- 
type actin. 
Results of various types of chemical experiments have 
suggested that the DNase I-binding loop is involved in 
inter-monomer binding in the actin filament. This is 
supported by the observation that pol~erization of 
P38A actin is slightly aberrant, as seen by a prolonged 
lag-phase and an increased Acc,k value. This is conso- 
nant with the filament model of Holmes and co-workers 
[21], as well as with the ribbon structure of actin conjec- 
tured to be an extended and untwisted form of helical 
actin [39]. Thus, it is not possible to discriminate be- 
tween these two filament models on the basis of the 
current data, even though the pattern of interactions in 
the two models are completely different (C.E. Schutt et 
al., submitted). 
The strong interference of Mg”-induced polymeriza- 
tion by the C374S mutation supports the observation 
that the actin C-terminus plays an important role in 
stabilizing monomer:monomer interactions in the fila- 
ment [21,40]. This is particularly evident from the co- 
polymerization experiment with wild-type actin de- 
scribed in Fig. 3. Our data therefore points towards 
subdomain I, and in particular the C-terminus, as form- 
ing a major inter-monomer binding site in the actin 
filament. 
The P38A mutation led to a small but significant 
decrease in the rate of actin filament translocation in the 
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in vitro motility assay, while decoration of the mutant 
actin with myosin Sl, and the ATPase activity of acto- 
Sl, was not significantly changed. The C374S actin be- 
haved similarly, but the movement of these mutant fila- 
ments was more strongly suppressed. The effect was of 
the same magnitude as that seen with mutations intro- 
duced at the actin N-terminus where the aspartic acid 
residues, D3 and D4, were deleted or replaced with 
alanines [9,11]. However, these latter mutations also 
altered the decoration of the actin with myosin Sl, and 
decreased the activity of the a&o-S1 ATPase measured 
in vitro, demonstrating amore severe disturbance of the 
act~myosin interaction in those cases. 
Thus, mutations in actin can impair the chemo-me- 
chanical transduction of the system, even though the 
acto-myosin rigor complex can form, and the ATPase 
activity of mixtures of actin and myosin in solution is 
retained. In the standard cross-bridge theory, the rela- 
tive movement of actin and myosin filaments is directly 
coupled to the myosin ATPase activity, and the velocity 
of the filaments should be independent of the number 
of ‘motor’ molecules acting on them (for reviews see 
[43,44]). The mutations introduced into actin in the 
present experiments, however, appear to have interfered 
with the coupling of the chemical reactions to mechani- 
cal events. One interpretation of this is that the proc- 
esses of acto-myosin-induced ATP hydrolysis and force 
generation engage different actin-myosin contacts, and 
that the first process can proceed relatively independent 
of the second. Alternatively these data may be inter- 
preted in view of the new model of energy transduction 
in the acto-myosin system that was recently proposed 
[45]. This model retains the element of tight coupling 
between myosin-binding and the myosin ATPase activ- 
ity, while placing force production in the actin molecule. 
The energy from the hydrolysis of ATP on myosin is 
used merely to initiate a transfo~ation of the actin 
filament into a metastable, stretched state (ribbon 
actin). Movements are generated when myosin-linked 
actin is returning to the ground state (helical actin). 
Interpreted in terms of the new model, this would mean 
that the initial myosin-dependent activation step is un- 
affected, but that the steps involving length changes in 
actin have been altered by the mutation. Results conso- 
nant with these ideas have also been obtained by others 
[20,46-49]. 
Under KC1 conditions (50 mM KCI; no Mg2+ added) 
protiin is an effective inhibitor of actin pol~erization. 
It forms a stable 1: 1 complex with /3-actin from the same 
source (miss < lo-* M), and if filamentous /I-actin is 
incubated with equimolar amounts of profilin in the 
absence of Mg 2+, the filaments are rapidly depolymer- 
ized, while in the presence of 1 mM Mg2’ plus 50 mM 
KCl, the I&,_ is increased more than lo-fold [36]. If the 
actin and profilin are from heterologous sources the 
complex formed is less stable, as indicated by a higher 
Kdlss value (>10m6 M) [36,50]. The Kdiss value for the 
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profilin:wild-type actin complex determined in this 
study (0.9 x 10m6 M) is in agreement with that deter- 
mined by others for a prolilin:non-muscle actin interac- 
tion [51], and it is in the same range as that determined 
for the interaction between actin and thymosin-B,, 
which is also known to be an actin monomer binding 
protein [50]. The reason for the slightly reduced Kdlss 
value observed for the profilin interaction with P38A 
actin is unknown. 
Removal of the C-terminal Phe-375 [52], or chemical 
modification of the penultimate cysteine residue [22,23], 
makes the actin resistant o profilin. This strongly sug- 
gests that profilin interacts with the C-terminus of actin, 
and that profilin thus should be a sensitive probe for 
structural changes in the C-terminal part of the actin 
molecule. The results obtained with the C374S mutant 
actin confirms that the structure of the actin C-terminus 
is of decisive importance for the formation of the 
profilin:actin complex. It is remarkable that the replace- 
ment of a cysteine SH-group with a serine OH-group 
can have such a dramatic effect on the profilin:actin 
interaction. It is possible that the C374S mutation 
causes the disruption of a larger structure element nor- 
mally contributing to the formation of the profilin bind- 
ing site on actin. It is noteworthy that the stabilization 
of profilin:actin crystals seemed to be especially sensi- 
tive to mercurials and other alkylating agents, and their 
use had to be avoided in obtaining the heavy-atom de- 
rivatives needed for phasing the structure factors [40]. 
Several lines of evidence suggest that the C-terminal 
region is part of a sensitive mechanism influencing the 
behaviour of the actin molecule. 
Recent evidence from genetic studies in yeast con- 
firms that the C-terminus of the actin molecule is phys- 
iologically important [ 171. Deleting one, two or three 
residues from the C-terminal (-KCF,,,) sequence 
causes increasing disturbance of the yeast phenotype, 
with lethality as the ultimate consequence when all three 
are removed. The same report showed that mutations 
at residues 373 or 374 (K373M and C374A), introduced 
separately or together, had no effect on cell viability. In 
all three cases, the yeast cells appeared to exhibit a 
wild-type phenotype. This reinforces the concept of a 
physiologically important and sensitive structure in- 
volving the C-terminal amino acid sequence -KCF,,,,. 
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